Feb. 12, 2024 Price forecast | 2 weeks: -2.93% | 1 month: -5.79% | 3 months: -7.90%


PCSA stock forecast

Our latest prediction for Processa Pharmaceuticals Inc's stock price was made on the Feb. 12, 2024 when the stock price was at 2.48$.

In the short term (2weeks), PCSA's stock price should underperform the market by -2.93%. During that period the price should oscillate between -76.91% and +68.45%.

In the medium term (3months), PCSA's stock price should underperform the market by -7.90%. During that period the price should oscillate between -194.91% and +169.94%.

Create a solid portfolio with PCSA

Add PCSA to your portfolio and optimize it!


About Processa Pharmaceuticals Inc

processa pharmaceuticals was founded in october 2017 with a mission to develop products that can improve the survival and/or quality of life for patients who have a high unmet medical need. the company is headquartered in hanover, maryland.

At the moment the company doesn't generate any revenue.

On its last earning announcement, the company reported a loss of -1.17$ per share.

The book value per share is 1.20$

Processa Pharmaceuticals Inc website


Three months stock forecastFeb. 12, 2024


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
- - -22M - -21M -1.17 - - 24M 1.20 - - -